| P2093 | author name string | Y Zhang | |
| | J-L Zhang | |
| | C-H Yin | |
| | H-J Fu | |
| | J-C Feng | |
| | L-B Zhao | |
| P2860 | cites work | Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q22306347 |
| | Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment | Q22306370 |
| | Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. | Q30878935 |
| | Copeptin is associated with mortality and outcome in patients with acute intracerebral hemorrhage | Q33588084 |
| | C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study | Q34003454 |
| | The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department | Q34134378 |
| | Copeptin and risk stratification in patients with acute dyspnea | Q35561316 |
| | Vasopressinergic regulation of the hypothalamic pituitary adrenal axis and stress adaptation | Q35932050 |
| | Vasopressin and vasopressin receptor antagonists in heart failure | Q37353656 |
| | Hyperfibrinogenemia and functional outcome from acute ischemic stroke | Q37414498 |
| | Blood markers for the prognosis of ischemic stroke: a systematic review | Q37415033 |
| | Predicting post-stroke infections and outcome with blood-based immune and stress markers | Q38019812 |
| | Stress hormones predict cerebrovascular re-events after transient ischemic attacks | Q39794296 |
| | Copeptin: a novel, independent prognostic marker in patients with ischemic stroke | Q43207505 |
| | Vasopressin-induced protein kinase C-dependent superoxide generation contributes to atp-sensitive potassium channel but not calcium-sensitive potassium channel function impairment after brain injury | Q43626851 |
| | Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model | Q44240540 |
| | Elevated C-reactive protein and long-term mortality after ischaemic stroke: relationship with markers of endothelial cell and platelet activation | Q45118321 |
| | Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia. | Q45296344 |
| | Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin | Q46790418 |
| | Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study | Q46862725 |
| | Serum vasopressin concentrations in critically ill patients | Q46902577 |
| | Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure | Q48252671 |
| | High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke | Q48389128 |
| | Hypercortisolism after stroke--partly cytokine-mediated? | Q48762561 |
| | Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke | Q49119777 |
| | Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. | Q52925939 |
| | Prognostic Value of Copeptin | Q57759280 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 372-380 | |
| P577 | publication date | 2013-04-25 | |
| P1433 | published in | Acta Neurologica Scandinavica | Q4676732 |
| P1476 | title | Plasma copeptin and long-term outcomes in acute ischemic stroke | |
| P478 | volume | 128 | |